呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2021 SPLF指南：哮喘患者的管理和随访（更新版）

2022-05-05 法国呼吸系统疾病学会 Respir Med Res

哮喘

2022年5月，法国呼吸系统疾病学会(SPLF)更新发布了哮喘患者的管理和随访指南。主要内容涉及12岁及以上青少年和成人哮喘患者的管理和随访，包括哮喘的初步诊断，哮喘患者的过敏检查，哮喘恶化以及难治性

中文标题：

2021 SPLF指南：哮喘患者的管理和随访（更新版）

英文标题：

Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version

发布机构：

法国呼吸系统疾病学会

发布日期：

2022-05-05

简要介绍：

2022年5月，法国呼吸系统疾病学会(SPLF)更新发布了哮喘患者的管理和随访指南。主要内容涉及12岁及以上青少年和成人哮喘患者的管理和随访，包括哮喘的初步诊断，哮喘患者的过敏检查，哮喘恶化以及难治性哮喘的管理，妊娠期间哮喘的管理等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 SPLF指南：哮喘患者的管理和随访（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bcd1c1c002a342fc, title=2021 SPLF指南：哮喘患者的管理和随访（更新版）, enTitle=Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version, guiderFrom=Respir Med Res, authorId=0, author=, summary=2022年5月，法国呼吸系统疾病学会(SPLF)更新发布了哮喘患者的管理和随访指南。主要内容涉及12岁及以上青少年和成人哮喘患者的管理和随访，包括哮喘的初步诊断，哮喘患者的过敏检查，哮喘恶化以及难治性, cover=https://img.medsci.cn/20220510/1652160669948_1608702.jpg, journalId=0, articlesId=null, associationId=2481, associationName=法国呼吸系统疾病学会, associationIntro=法国呼吸系统疾病学会(SPLF,French Society of Respiratory Diseases), copyright=0, guiderPublishedTime=Thu May 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年5月，法国呼吸系统疾病学会(SPLF)更新发布了哮喘患者的管理和随访指南。主要内容涉及12岁及以上青少年和成人哮喘患者的管理和随访，包括哮喘的初步诊断，哮喘患者的过敏检查，哮喘恶化以及难治性哮喘的管理，妊娠期间哮喘的管理等。</span></p>, tagList=[TagDto(tagId=441, tagName=哮喘)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3212, appHits=128, showAppHits=0, pcHits=298, showPcHits=3080, likes=0, shares=27, comments=3, approvalStatus=1, publishedTime=Tue May 10 15:29:00 CST 2022, publishedTimeString=2022-05-05, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue May 10 13:33:35 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 09:37:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SPLF指南：哮喘患者的管理和随访（更新版）.pdf)])
2021 SPLF指南：哮喘患者的管理和随访（更新版）.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219099, encodeId=13a31219099fc, content=14岁以上哮喘患者治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2546901, createdName=12532b5cm46暂无昵称, createdTime=Thu May 12 14:50:15 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218655, encodeId=9488121865595, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc8157497, createdName=ms2000001940001184, createdTime=Wed May 11 08:34:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218526, encodeId=06f012185266c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:15 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-12 12532b5cm46暂无昵称

    14岁以上哮喘患者治疗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219099, encodeId=13a31219099fc, content=14岁以上哮喘患者治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2546901, createdName=12532b5cm46暂无昵称, createdTime=Thu May 12 14:50:15 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218655, encodeId=9488121865595, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc8157497, createdName=ms2000001940001184, createdTime=Wed May 11 08:34:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218526, encodeId=06f012185266c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:15 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-11 ms2000001940001184

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219099, encodeId=13a31219099fc, content=14岁以上哮喘患者治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2546901, createdName=12532b5cm46暂无昵称, createdTime=Thu May 12 14:50:15 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218655, encodeId=9488121865595, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc8157497, createdName=ms2000001940001184, createdTime=Wed May 11 08:34:09 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218526, encodeId=06f012185266c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e556504447, createdName=ms9000002138466017, createdTime=Tue May 10 19:22:15 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 ms9000002138466017

    学习

    0

相关指南

2021 SATS立场声明：成人和青少年哮喘的管理指南（更新版）

南非胸科学会(SATS,South African Thoracic Society) · 2021-12-31

2021 TSANZ意见书：成人和青少年哮喘口服皮质类固醇治疗管理

澳大利亚和新西兰胸科学会(TSANZ,Thoracic Society of Australia and New Zealand) · 2021-09-29

2020 国家哮喘教育和预防计划指南：青少年和成人哮喘的管理

国外呼吸科专家组（统称） · 2020-12-03

2020 JSA指南：儿童时期哮喘

日本变态反应学会(JSA,Japanese Society of Allergology) · 2020-07-09

2020 多学科共识：哮喘的吸入治疗

国外呼吸科专家组（统称） · 2020-11-10

2020 TSANZ/NAC意见书：工作相关性哮喘

澳大利亚和新西兰胸科学会(TSANZ,Thoracic Society of Australia and New Zealand) · 2020-10-05